IUHSA
Itau Unibanco Holding S.A. Portfolio holdings
AUM
$2.63B
1-Year Return
21.65%
This Quarter Return
-1.74%
1 Year Return
+21.65%
3 Year Return
+79.74%
5 Year Return
+135.75%
10 Year Return
–
AUM
$3.2B
AUM Growth
+$169M
(+5.6%)
Cap. Flow
+$258M
Cap. Flow
% of AUM
8.05%
Top 10 Holdings %
Top 10 Hldgs %
57.99%
Holding
441
New
116
Increased
148
Reduced
92
Closed
76
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$250M |
| 2 |
Credicorp
BAP
|
$206M |
| 3 |
Petrobras
PBR
|
$198M |
| 4 |
NVIDIA
NVDA
|
$41.1M |
| 5 |
America Movil
AMX
|
$40.3M |
Top Sells
| 1 |
iShares 10-20 Year Treasury Bond ETF
TLH
|
$119M |
| 2 |
TSMC
TSM
|
$112M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
$111M |
| 4 |
Coca-Cola Femsa
KOF
|
$68.3M |
| 5 |
Vale
VALE
|
$65M |
Sector Composition
| 1 | Financials | 17.35% |
| 2 | Energy | 13.4% |
| 3 | Technology | 11.63% |
| 4 | Communication Services | 9.21% |
| 5 | Consumer Discretionary | 4.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Agilent Technologies
A
$36.4B
| $41.6K | ﹤0.01% |
310
-109
| -26% | -$14.6K |
|
|
DFS
277
DELISTED
Discover Financial Services
DFS
| $41.6K | ﹤0.01% |
240
+187
| +353% | +$32.4K |
|
278
Revvity
RVTY
$9.95B
| $41.5K | ﹤0.01% |
372
-223
| -37% | -$24.9K |
|
279
Insulet
PODD
$24.4B
| $41.5K | ﹤0.01% |
+159
| New | +$41.5K |
|
280
Ametek
AME
$43.4B
| $41.4K | ﹤0.01% |
159
-41
| -21% | -$10.7K |
|
281
Incyte
INCY
$16.7B
| $41.4K | ﹤0.01% |
599
-375
| -39% | -$25.9K |
|
282
HP
HPQ
$27B
| $41.1K | ﹤0.01% |
1,260
+154
| +14% | +$5.03K |
|
283
BridgeBio Pharma
BBIO
$9.91B
| $41.1K | ﹤0.01% |
+1,498
| New | +$41.1K |
|
284
Hasbro
HAS
$11.3B
| $41K | ﹤0.01% |
733
+178
| +32% | +$9.95K |
|
285
Lennar Class A
LEN
$35.8B
| $40.8K | ﹤0.01% |
309
+266
| +619% | +$35.1K |
|
286
Bio-Techne
TECH
$8.23B
| $40.7K | ﹤0.01% |
+565
| New | +$40.7K |
|
287
Otis Worldwide
OTIS
$33.9B
| $40.6K | ﹤0.01% |
438
+361
| +469% | +$33.4K |
|
288
Old Dominion Freight Line
ODFL
$31.3B
| $40.4K | ﹤0.01% |
229
+192
| +519% | +$33.9K |
|
289
Repligen
RGEN
$6.78B
| $40.3K | ﹤0.01% |
+280
| New | +$40.3K |
|
290
Ionis Pharmaceuticals
IONS
$9.46B
| $40.2K | ﹤0.01% |
1,151
+70
| +6% | +$2.45K |
|
291
Alnylam Pharmaceuticals
ALNY
$59.4B
| $40.2K | ﹤0.01% |
171
-137
| -44% | -$32.2K |
|
292
Gartner
IT
$17.9B
| $40.2K | ﹤0.01% |
83
+68
| +453% | +$32.9K |
|
293
Snowflake
SNOW
$74B
| $40.2K | ﹤0.01% |
260
| – | – |
|
294
Unity
U
$17B
| $40K | ﹤0.01% |
1,778
+1,068
| +150% | +$24K |
|
295
Idexx Laboratories
IDXX
$51.2B
| $39.7K | ﹤0.01% |
96
+81
| +540% | +$33.5K |
|
296
Illumina
ILMN
$15.5B
| $39.3K | ﹤0.01% |
294
-179
| -38% | -$23.9K |
|
297
Exact Sciences
EXAS
$9.73B
| $38.6K | ﹤0.01% |
687
-141
| -17% | -$7.92K |
|
298
Veeva Systems
VEEV
$44.3B
| $38.1K | ﹤0.01% |
181
+144
| +389% | +$30.3K |
|
299
ResMed
RMD
$40.1B
| $37.7K | ﹤0.01% |
165
+150
| +1,000% | +$34.3K |
|
300
Vertex Pharmaceuticals
VRTX
$102B
| $37.5K | ﹤0.01% |
93
-60
| -39% | -$24.2K |
|